Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.70 (8.974%)
Open: 8.15
High: 8.15
Low: 8.15
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Production and Testing of µSaltTM

4 Jan 2017 07:00

RNS Number : 2511T
Tekcapital plc
04 January 2017
 
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)

 

Tekcapital plc

("Tekcapital" or "the Company")

 

Successful Production and Independent Testing of µSaltTM

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces a successful test-production and independent taste testing of µSaltTM, its proprietary, low-sodium salt product.

 

Successful Taste Tests

Tekcapital has manufactured test quantities of µSaltTM in a current Good Manufacturing Practice ("cGMP") facility regulated by the US Food and Drug Administration. Test quantities of µSaltTM were then supplied to several organisations for independent testing and evaluation. The results of the study indicate that a taste test of traditional potato chips versus those salted with µSaltTM, with approximately 40% less sodium than traditional potato chips, yielded no statistically significant difference in perceived salt flavour.

 

Technology Background

In 2016, Tekcapital announced that it acquired US patent #8,900,650 B1 for low-sodium salt compositions, which has the potential to enable the commercialisation of a 1:1 replacement for regular salt in a variety of applications including table-top, dry snacks such as chips and crisps, popcorn, cereals, and other dry surface applications that have salt in spice mixes.

 

Regular 'table salt' is not readily soluble in saliva because of its high density and large particles size. When regular salt particles are sprinkled on foods for immediate consumption or during further processing, they tend to provide low-intensity and long-lasting spotty salty tastes. The µSaltTM technology aims to deliver an improved dissolution, providing an equally salty taste as table salt with lower salt concentrations.

 

This innovative 'microsalt' does not contain substitutes like calcium, potassium or magnesium salts, which can impart the bitter taste that is typical of many existing low-sodium salt products. Furthermore, these nano particles dissolve faster and are tasted faster by the consumer, thereby allowing for the reduction of the concentration of salt in dry snacks where salt and spices are applied to the surface.

 

Key features of a commercialised version of this salt preparation would include, but may not be limited to, co-blending with spices, flavours, colours and flow agents and increasing salt dispersion while enhancing salt sensation in the mouth.

 

Market Potential

According to market research firm IBISWorld Inc., sales of table salt in the United States in 2013 were approximately $598.7 million1. Based on the recently completed results from an independent university test, the Directors believe that its µSaltTM low-sodium technology could enable food companies to empower consumers to reduce sodium content in topical food applications without sacrificing taste. Furthermore, the Directors believe that this will be helpful in enabling individuals to seek to reduce their sodium consumption to less than or equal to 2,300 mg per day, as recommended in the 2015-2020 Dietary Guidelines for Americans2.

 

 

 

Commenting on the announcement, Clifford M. Gross, Ph.D., Executive Chairman of Tekcapital plc, said:

"We are excited to report that we have produced and tested our natural µSaltTM product and have found that it provides a level of taste similar to traditional salt, but with approximately 40% less sodium. If widely adopted, we believe that the potential positive impact to improving the health of consumers could be significant. We are currently in discussions with a number of leading companies regarding commercialisation of this exciting new product and we will update the market in due course."

 

 

 

 

For further information, please contact:

 

Tekcapital Plc

+1 305 200 3450

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

+44 (0)20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

Notes

----------------------------------------------------

1. http://www.prweb.com/releases/2013/8/prweb11061887.htm 

2. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm494732.htm#ftn9

 

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUGUWWGUPMGMW
Date   Source Headline
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.